Academic hospital staff compliance with a fecal immunochemical test-based colorectal cancer screening program

被引:0
|
作者
Vlachonikolou, Georgia [1 ,2 ]
Gkolfakis, Paraskevas [1 ,2 ]
Sioulas, Athanasios D. [1 ,2 ]
Papanikolaou, Ioannis S. [1 ,2 ]
Melissaratou, Anastasia [1 ,2 ]
Moustafa, Giannis-Aimant [1 ,2 ]
Xanthopoulou, Eleni [1 ,2 ]
Tsilimidos, Gerasimos [1 ,2 ]
Tsironi, Ioanna [1 ,2 ]
Filippidis, Paraskevas [1 ,2 ]
Malli, Chrysoula [1 ,2 ]
Dimitriadis, George D. [1 ,2 ]
Triantafyllou, Konstantinos [1 ,2 ]
机构
[1] Univ Athens, Hepatogastroenterol Unit, Dept Internal Med 2, Attikon Univ Gen Hosp,Med Sch, 1 Rimini St, Athens 12462, Greece
[2] Univ Athens, Res Inst, Attikon Univ Gen Hosp, Sch Med, 1 Rimini St, Athens 12462, Greece
关键词
Colorectal cancer; Screening; Academic hospital staff; Fecal immunochemical test; Compliance; GUIDELINE;
D O I
10.4251/wjgo.v8.i8.629
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
AIM: To measure the compliance of an Academic Hospital staff with a colorectal cancer (CRC) screening program using fecal immunochemical test (FIT). METHODS: All employees of " Attikon" University General Hospital aged over 50 years were thoroughly informed by a team of physicians and medical students about the study aims and they were invited to undergo CRC screening using two rounds of FIT (DyoniFOB (R) Combo H, DyonMed SA, Athens, Greece). The tests were provided for free and subjects tested positive were subsequently referred for colonoscopy. One year after completing the two rounds, participants were asked to be re-screened by means of the same test. RESULTS: Among our target population consisted of 211 employees, 59 (27.9%) consented to participate, but only 41 (19.4%) and 24 (11.4%) completed the first and the second FIT round, respectively. Female gender was significantly associated with higher initial participation (P = 0.005) and test completion -first and second round - (P = 0.004 and P = 0.05) rates, respectively. Phy sician's (13.5% vs 70.2%, P < 0.0001) participation and test completion rates (7.5% vs 57.6%, P < 0.0001 for the first and 2.3% vs 34%, P < 0.0001 for the second round) were significantly lower compared to those of the administrative/technical staff. Similarly, nurses participated (25.8% vs 70.2%, P = 0.0002) and completed the first test round (19.3% vs 57.6%, P = 0.004) in a significant lower rate than the administrative/technical staff. One test proved false positive. No participant repeated the test one year later. CONCLUSION: Despite the well-organized, guided and supervised provision of the service, the compliance of the Academic Hospital personnel with a FIT-based CRC screening program was suboptimal, especially among physicians.
引用
收藏
页码:629 / 634
页数:6
相关论文
共 50 条
  • [1] Academic hospital staff compliance with a fecal immunochemical test-based colorectal cancer screening program
    Georgia Vlachonikolou
    Paraskevas Gkolfakis
    Athanasios D Sioulas
    Ioannis S Papanikolaou
    Anastasia Melissaratou
    Giannis-Aimant Moustafa
    Eleni Xanthopoulou
    Gerasimos Tsilimidos
    Ioanna Tsironi
    Paraskevas Filippidis
    Chrysoula Malli
    George D Dimitriadis
    Konstantinos Triantafyllou
    World Journal of Gastrointestinal Oncology, 2016, (08) : 629 - 634
  • [2] Quality Metrics of a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program in Korea
    Kim, Dae Ho
    Cha, Jae Myung
    Kwak, Min Seob
    Yoon, Jin Young
    Cho, Young-Hak
    Jeon, Jung Won
    Shin, Hyun Phil
    Joo, Kwang Ro
    Lee, Joung Il
    GUT AND LIVER, 2018, 12 (02) : 183 - 189
  • [3] Fecal immunochemical test-based colorectal cancer screening: The gender dilemma
    Grobbee, Esmee J.
    Wieten, Els
    Hansen, Bettina E.
    Stoop, Esther M.
    de Wijkerslooth, Thomas R.
    Lansdorp-Vogelaar, Iris
    Bossuyt, Patrick M.
    Dekker, Evelien
    Kuipers, Ernst J.
    Spaander, Manon C. W.
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2017, 5 (03) : 448 - 454
  • [4] Colonoscopy-Related Mortality in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program
    Kooyker, Arthur I.
    Toes-Zoutendijk, Esther
    Opstal-van Winden, Annemieke W. J.
    Buskermolen, Maaike
    van Vuuren, Hanneke J.
    Kuipers, Ernst J.
    van Kemenade, Folkert J.
    Ramakers, Chris
    Dekker, Evelien
    Nagtegaal, Iris D.
    de Koning, Harry J.
    Spaander, Manon C. W.
    Lansdorp-Vogelaar, Iris
    van Leerdam, Monique E.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (07) : 1418 - 1425
  • [5] Predictive Modeling of Colonoscopic Findings in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program
    Jade Law
    Anand Rajan
    Harry Trieu
    John Azizian
    Rani Berry
    Simon W. Beaven
    James H. Tabibian
    Digestive Diseases and Sciences, 2022, 67 : 2842 - 2848
  • [6] Post-colonoscopy colorectal cancers in a national fecal immunochemical test-based colorectal cancer screening program
    Wisse, Pieter H. A.
    de Boer, Sybrand Y.
    Pool, Marco Oudkerk
    Droste, Jochim S. Terhaar sive
    Verveer, Claudia
    Meijer, Gerrit A.
    Dekker, Evelien
    Spaander, Manon C. W.
    ENDOSCOPY, 2024, 56 (05) : 364 - 372
  • [7] An advance notification letter increases participation in a fecal immunochemical test-based colorectal cancer screening program
    Cole, Stephen R.
    Smith, Alicia
    Wilson, Carlene
    Turnbull, Deborah
    Esterman, Adrian
    Young, Graerne P.
    GASTROENTEROLOGY, 2006, 130 (04) : A187 - A187
  • [8] Costs and Benefits of an Organized Fecal Immunochemical Test-Based Colorectal Cancer Screening Program in the United States
    Guy, Gery P., Jr.
    Richardson, Lisa C.
    Pignone, Michael P.
    Plescia, Marcus
    CANCER, 2014, 120 (15) : 2308 - 2315
  • [9] Predictive Modeling of Colonoscopic Findings in a Fecal-Immunochemical Test-Based Colorectal Cancer Screening Program
    Law, Jade
    Rajan, Anand
    Trieu, Harry
    Azizian, John
    Berry, Rani
    Beaven, Simon W.
    Tabibian, James H.
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (07) : 2842 - 2848
  • [10] Diagnostic Performance of a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program According to Ambient Temperature and Humidity
    Ibanez-Sanz, Gemma
    Mila, Nuria
    Vives, Nuria
    Vidal, Carmen
    Binefa, Gemma
    Rocamora, Judith
    Atencia, Carmen
    Moreno, Victor
    Sanz-Pamplona, Rebeca
    Garcia, Montse
    CANCERS, 2022, 14 (05)